Home
>
US Stocks
>
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc
SRPT

Sarepta Therapeutics Inc

$84.277.58%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
83.25
Today Low/High
82.61 / 85.69
52 Week Low/High
$65.3 / $181.83
P/E ratio
-9.802
Market Cap
$6.22B

Company Details

Sarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company's programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing.
Organisation
Sarepta Therapeutics Inc
Headquaters
Cambridge, Massachusetts, US
Employees
866
Industry
Health Technology
CEO
Douglas Ingram

Discover more

Frequently Asked Questions

What is Sarepta Therapeutics Inc share price today

Can Indians buy Sarepta Therapeutics Inc shares?

How can I buy Sarepta Therapeutics Inc shares from India?

Can Fractional shares of Sarepta Therapeutics Inc be purchased?

What are the documents required to start investing in Sarepta Therapeutics Inc stocks?

We are a SEBI registered investement advisor